chrisvoncsefalvay/vaers-outcomes huggingface dataset:
"I was going to pass out, thought I was going to die"; dry heaves; burning sensation inside my body; Severe Diarrhea; I had chills; headache; Feeling sick; This is a spontaneous report from a contactable consumer.   A 70-year-old elderly female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration, administered in Right Arm on 23Feb2021 (Batch/Lot Number: EN6202) as SINGLE DOSE for covid-19 immunisation.  Dose 1 of BNT162B2 for COVID-19 immunisation was given on 29Jan2021 lot number unknown in right arm.  Medical history included macular degeneration from an unknown date, glaucoma from an unknown date, hypertension from an unknown date (controlled), and herpes zoster from 2017 to an unknown date. The patient is not pregnant. The patient did not have Covid-19 prior vaccination. The patient had no known allergies.  Concomitant medications included losartan (LOSARTAN) taken for an unspecified indication, start and stop date were not reported; amlodipine besilate (AMLODIPINE BESILATE) taken for an unspecified indication, start and stop date were not reported; and carvedilol (CARVEDILOL) taken for an unspecified indication, start and stop date were not reported.  Other medications in two weeks also included unspecified eye drops for glaucoma. No other vaccine was given in last four weeks.  The patient experienced "I was going to pass out, thought I was going to die" on 24Feb2021, dry heaves on 24Feb2021 with outcome of recovered, burning sensation inside my body on 24Feb2021 with outcome of recovered, severe diarrhea on 24Feb2021 with outcome of recovered, chills on 24Feb2021 with outcome of recovered, headache on 24Feb2021 with outcome of recovered and feeling sick on 24Feb2021 with outcome of recovered.  All events recovered on an unspecified date in 2021.  The patient was not Covid tested post vaccination.  No follow-up attempts are possible; No further information is expected.
Far more than expected ache/pain in right arm (injection site), right leg, right foot, left arm muscles, and all joints. Severe fatigue. Some elevated heart rate. 36 hours duration.
Swelling of Left upper from top of arm to 1/2 way to elbow. On 1/31/21 the swelling decreases but redness started from mid upper arm to elbow with itching..
After the vaccination, dull pain persisted at the injection site (right deltoid) until the onset of the adverse affect.  Several weeks after the vaccine was administered, a painful rash developed at the site of the injection and spread down my right arm and hand. I thought the rash was poison ivy or poison oak except the pain was excruciating. So I visited our GP and was diagnosed with shingles. He prescribed 10 days of Valacyclovir and Gabapentin. As of today 6/20 part of the rash has healed except some festering scabs on and near the vaccine injection site. I am currently experiencing severe pain / sensitivity in my entire right arm.
THROAT TIGHT AND TONGUE NUMBNESS. TONGUE FELT HEAVY. HAPPENED WITHIN 5 MINS OF INJECTION. I TOOK LIQUID BENADRYL AND A GEL BENADRYL CAPSAL.   THIS HAPPENED ALSO WITH THE SECOND COVID VACCINE. I TURNED IN A MEDICAL EXCEMPTION FOR MY SECOND DOSE AND WAS DENIED THE EXCEMPTION. MY ORGANIZATION IS MANDATING EMPLOYEES TO BE VACCINATED. I AM NOW AFRAID TO GET A BOOSTER. ANY THOUGHTS OR RECCOMENDATIONS APPRECIATED
severe red rash/hives on bilateral arms. Very itchy. spread drom hands up to shoulders, Benadryl and Prednisone taper
shoulder rigid/neck got really stiff; shoulder really tender; neck got really tender; tiredness/felt exhausted; flu symptoms; This case was reported by a consumer and described the occurrence of stiffness shoulder in a adult male patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, 3 hrs after receiving Shingrix, the patient experienced stiffness shoulder, shoulder pain, neck pain, exhaustion and flu symptoms. On an unknown date, the outcome of the stiffness shoulder was recovered/resolved and the outcome of the shoulder pain, neck pain, exhaustion and flu symptoms were unknown.   It was unknown if the reporter considered the stiffness shoulder, shoulder pain, neck pain, exhaustion and flu symptoms to be related to Shingrix.  Additional details were provided as follows: The reporter was the patient's son. The patient recently received the Shingrix vaccine (from date of reporting). The patient reported that anyway, about 3 hours after the vaccination with Shingrix, his shoulder on the shot side and neck got really stiff and tender, and the patient felt exhausted, but the patient got a good night's sleep and woke up. The reporter said that still stiff but it went away by midday (on the day of vaccination).  The reaction was in line with the flu like symptoms that he was told to expect. The reporter consented to follow up.
mild fever; drowsiness; This is a spontaneous report from a non-contactable consumer.   A 66-year-old female patient received pneumococcal 13-val conj vac (dipht crm197 protein) (PREVNAR 13) , on an unspecified date at single dose for immunisation. The patient medical history and concomitant medications were not reported. The patient experienced mild fever and drowsiness on an unspecified date, within a few hours of receiving the vaccine. The outcome of the events was unknown. No follow-up attempts are possible, information about batch number cannot be obtained.
Developed diarrhea and vomiting 2 days after administering Rotavirus vaccine on 8/8/07. Has not resolved 8/28/07 visit.
electrical shock going through her left arm/tingling in her left arm; opening and closing her left hand hurts; the joints in her left hand hurt; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (electrical shock going through her left arm/tingling in her left arm), PAIN IN EXTREMITY (opening and closing her left hand hurts) and ARTHRALGIA (the joints in her left hand hurt) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0100A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported.)    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Mar-2021, the patient experienced PARAESTHESIA (electrical shock going through her left arm/tingling in her left arm), PAIN IN EXTREMITY (opening and closing her left hand hurts) and ARTHRALGIA (the joints in her left hand hurt). At the time of the report, PARAESTHESIA (electrical shock going through her left arm/tingling in her left arm), PAIN IN EXTREMITY (opening and closing her left hand hurts) and ARTHRALGIA (the joints in her left hand hurt) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
numbness of lips, cough- fever chills, severe body aches pain, numbness in legs on right side , muscle weakness, difficulty walking,  right sided facial numbness, headache, parasthesia, chest tightness
No adverse event; Patient received RECOMBIVAX HB on 24-OCT-2023 and again on accident on 27-OCT-2023; This spontaneous report has been received from a registered nurse concerning a 19-year-old patient of unknown gender.  The patient's concurrent conditions, medical history, concomitant therapies, and allergy/drug reactions were not reported.  On 24-OCT-2023, the patient was vaccinated with hepatitis B vaccine (recombinant) (RECOMBIVAX HB) (dose/route/frequency of administration, lot number, and expiration date not reported) for prophylaxis. On 27-OCT-2023, the patient was accidentally vaccinated again with hepatitis B vaccine (recombinant) thimerosal-free (RECOMBIVAX HB) (lot number W036194 with expiry date 29-SEP-2025) dose: 1 dose (route/frequency of administration not reported) as prophylaxis (inappropriate schedule of product administration). The patient did not experience adverse events (no adverse event). The operator of the device was the health care professional.
This was a sudden onset of shakiness,abd discomfort,nausea,completely drenched in sweat.Upon returning home BP was 210/116 HR 130 at rest.I took 25 mg atenolol and BP + HR improved.The next morning I awake with orbital left eye pain and edema under eye Plus a small stye that my MD ordered a antibiotic .......after 4 days it was better.Since that day on Oct 5th I've had numbness in my lower legs and feet and my right arm musles are weak and very sore after performing work.
On 1/1 I developed a fever and headache and was not feeling well. On 1/3 my sense of smell lessened so I reached out to my PCP who recommended a COVID test and on 1/4 I tested positive to COVID. And to date I am getting better.
No additional adverse effects; Adult female patient following a steam cell transplant, who received a dose of LIQUID PEDVAXHIB, as prescribed by her physician; This spontaneous report was received from a pharmacist, referring to an adult female patient of unknown age. The patient's historical conditions included a stem cell transplant; her concurrent conditions, concomitant therapies and previous drug reactions or allergies were not provided.  On 31-MAR-2020, the patient was vaccinated with haemophilus b conjugate vaccine (meningococcal protein conjugate)(LIQUID PEDVAXHIB) at a dose of 0.5 milliliter (mL), intramuscularly (IM) (formulation, vaccination schedule, and site of vaccination were not provided; lot numer R004962 verified to be valid, expiration date of 20-NOV-2020) as prophylaxis, per physician's prescription (product use issue). No additional adverse effects were reported.
Jan. 29 (evening): mild headache, mild chills, pain at injection site Jan. 30 (all day): moderate headache, chills, aching (muscles), fatigue, low-grade fever (100.2), mild nausea, sore upper arm Jan. 31: mild headache, mild muscle/joint ache, chills, fatigue, pain at injection site, loss of appetite Feb. 1: mild pain at injection site Feb. 2:  all symptoms resolved
Saturday afternoon started having pain up by lt ear hurt when drank cole beverages, pain then got worse, radiated to lt jaw;glands swollen by both ears;painful to chew hard foods;h/a started the day p/vax;went to ER;
A few spots were slightly itchy; red scaly spots / I noticed he had some of the same kind of spots; red scaly spots / I noticed he had some of the same kind of spots; This case was reported by a consumer and described the occurrence of exfoliation in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   In January 2020, the patient received the 1st dose of Shingrix. On an unknown date, less than 2 months after receiving Shingrix, the patient experienced exfoliation, erythromacular rash and itchy rash. The patient was treated with cortisone (non-proprietary) (Cortisone Cream), antibiotics nos (Antibiotic Ointment (Unknown Ingredients)), ketoconazole (Ketoconazole Cream) and emollients and protectives (Moisturizer). On an unknown date, the outcome of the exfoliation and erythromacular rash were recovered/resolved and the outcome of the itchy rash was unknown.   It was unknown if the reporter considered the exfoliation, erythromacular rash and itchy rash to be related to Shingrix.  Additional details were reported as follows: The age at vaccination was not reported. The patient received Shingrix vaccione about a month ago from reporting date and got few random red scaly spots on body. A few spots were slightly itchy. The patient tried cortisone cream, antibiotic ointment, Ketoconazole cream and moisturizer on the spots but nothing seems to affect them. They eventually fade after about 3 weeks. The patient wanted to know whether it was common after receiving shingrix vaccine. This case has been linked with US2020AMR032951, reported by same reporter.
Headache starting 6:30 a.m and continuing 1/28, nausea starting 11:00 a.m. and continuing1/28, chills starting 3:30 p.m.  and continuing 1/28, fatigue starting 3:30 p.m.  and continuing 1/28, injection site sore and swollen starting 6:30 a.m. 1/28, brain zaps upon head movement starting 12:00 p.m.  and continuing 1/28.  All symptoms starting 1/28
Hospitalized 7NOV90 w/dx of CHF. In & out hosp over next few wks. Released again on 7DEC90 but readmitted 9DEC90 & died CHF. Not able to provide any other symptoms.
Beginning 1 week after vaccination, person (me) has suffered a series of momentary neuromuscular failures in limbs during moments of activity: wk 1 left knee; wk 4 left shoulder; wk 5 right shoulder; and wk 10 right knee. Loss of muscle control resulted in sprained and torn tendons in the first three instances. The week 10 right knee was a collapse - a loss of all strength - resulting in a fall with whiplash to the person and continued inability to stand erect without severe pain despite physical therapy.
Patient thought he had bronchitis, went to ER but it was a heart attack, Patient passed away; This spontaneous case was reported by a consumer and describes the occurrence of MYOCARDIAL INFARCTION (Patient thought he had bronchitis, went to ER but it was a heart attack, Patient passed away) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In April 2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In 2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 30-Apr-2021, the patient experienced MYOCARDIAL INFARCTION (Patient thought he had bronchitis, went to ER but it was a heart attack, Patient passed away) (seriousness criteria death and medically significant). The patient died on 06-May-2021. The reported cause of death was Heart attack. It is unknown if an autopsy was performed.            Concomitant product use was not provided by the reporter.  The AE caused the patient to seek medical care included ER (emergency room) visit.  No treatment information was provided.  Company comment: This is a spontaneous case concerning a 64 year-old, male patient with no reported medical history, who experienced the Fatal serious (medically significant) unexpected, AESI of Myocardial infarction. The event occurred after the second dose of mRNA-1273 vaccine, vaccination exact date not provided. The patient died 6 days after the onset of the event. It is unknown whether an autopsy was performed. The cause of death was reported as Myocardial infarction. No further clinical information was available for medical review. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.   Most recent FOLLOW-UP information incorporated above includes: On 24-Feb-2022: Follow-up received contains no new information. On 24-Feb-2022: Follow-up received contains no new information.; Sender's Comments: This is a spontaneous case concerning a 64 year-old, male patient with no reported medical history, who experienced the Fatal serious (medically significant) unexpected, AESI of Myocardial infarction. The event occurred after the second dose of mRNA-1273 vaccine, vaccination exact date not provided. The patient died 6 days after the onset of the event. It is unknown whether an autopsy was performed. The cause of death was reported as Myocardial infarction. No further clinical information was available for medical review. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.; Reported Cause(s) of Death: Heart attack
Nausea, upset stomach, no appetite, fever of 101.7 degrees F for 3 days (relieved by Tylenol), extreme fatigue for 4 days, depressed mood for several days.
patient received the MMR & Varicella vaccines in the left anterior thigh.  She had a large area of redness with an irregular border present over the area of the injection in less than 2 minutes after the injection was given.  She received the Hep A and Prevnar in the right anterior thigh, and had a similar area of redness in that leg, though not as large, nor as red.  No edema was noted.  The patient's face was the only other area that was slightly red, and just on her cheeks.  Mother says child has not had any procedures done in the past; no knowledge of laytex allergy.  Both LPN and NP were wearing gloves while holding the child during the vaccine administartion.  Allergy sectionb of patient;s clinic chart lists adverse reaction to Omnicef as "bloody diarrhea".  Patient was afebrile at the time of the visit.  She cried during and after the shots, but remained alert and awake during the time of monitoring.  She showed no signs of lethargy, no swelling or periorbital or perioral area, and no SOB or wheezing.  The redness on both legs remained at the time of discharge.  She was given Benadryl liquid 2.5 ccs and Prelone syrup 2.5cc shortly after the reaction.
My arm has been extremely sore; Didn't have a taste/I could barely taste it; Loss of smell for 48 hours; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (My arm has been extremely sore), AGEUSIA (Didn't have a taste/I could barely taste it) and ANOSMIA (Loss of smell for 48 hours) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Apr-2021, the patient experienced ANOSMIA (Loss of smell for 48 hours). On an unknown date, the patient experienced PAIN IN EXTREMITY (My arm has been extremely sore) and AGEUSIA (Didn't have a taste/I could barely taste it). On 16-Apr-2021, ANOSMIA (Loss of smell for 48 hours) had resolved. At the time of the report, PAIN IN EXTREMITY (My arm has been extremely sore) and AGEUSIA (Didn't have a taste/I could barely taste it) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: negative (Negative) Negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.  No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 16-Jul-2021: Follow up received and added reporter details, patient demographics, lab data, suspect drug details and new event.
Missed miscarriage diagnosed at 20 weeks. The baby died 5 days after vaccine dose 2 at 16.5 weeks. No abnormalities in previous scans. Placenta pathology noted inflammation and infection.
SOB, hypoxia due to COVID Pneumonia. acute on chronic CHF, asthma. dexamethasone, lasix, doxycycline, 2L O2 NC.  Home on RA
angioedema (upper lip swelling, periorbital swelling, hand swelling and tingling) the next day
Patient after receiving COVID vaccine and was waiting the required 15 minutes, patient fainted while getting up. First blood pressure was 100/60 while laying down. Patient was conscious, just said he got dizzy and lightheaded. Patient indicated he had not ate in the morning. Second blood pressure was 118/78. Patient does have history of syncope
Cellulitis; This case was reported by a consumer via interactive digital media and described the occurrence of cellulitis in a patient who received Men B NVS (Meningococcal B vaccine) for prophylaxis.   On an unknown date, the patient received Meningococcal B vaccine. On an unknown date, unknown after receiving Meningococcal B vaccine, the patient experienced cellulitis (serious criteria GSK medically significant). On an unknown date, the outcome of the cellulitis was unknown.   It was unknown if the reporter considered the cellulitis to be related to Meningococcal B vaccine.  Additional information was provided as follows: The age at vaccination was not reported. It was cellulitis what occuring to the patient after receiving vaccine. The case was linked with case US2020AMR118262, reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020AMR118262:Same reporter
body pain; Muscle pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (body pain) and MYALGIA (Muscle pain) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Apr-2021, the patient experienced PAIN (body pain) and MYALGIA (Muscle pain). At the time of the report, PAIN (body pain) and MYALGIA (Muscle pain) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No treatment information provided by Reporter.
Large, reddened, oval shaped area approximately 6 inches at widest span and approximately 6 inches long, with the start of the area beginning just under the injection site on left arm, warm to touch, reddened area appears 'rash' like and has inconsistency in color as it appears 'patchy' in some areas, darkest reddened area is approximately the last 2.5 to  3 inches of the lower area most distal to the injection site and rightside of the reddenedarea, no pain or itching noted at this time.
pt recv vax 10MAY05 & arm sore, pain in arm inc 11MAY95 accompanied by flu-like sz;
Moderna COVID-19 Vaccine EUA Rash at injection site occurred approximately 9 days after administration. Rash was itchy.
I had flu like symptoms, chills, low fever, nausea, and body aches.  This lasted for 2 days.
He got his vaccine, he asked them about taking 2 vaccines (including Pneumovax in the right arm), and they told him that it was fine. He usually goes to bed about 8:00 PM, and he went to go to bed, laid down and got up around 9:00 PM and went to get some water and noticed that his face was puffy and swollen, felt wheezy. He got up and went to the UC. They treated him with a shot (Benadryl), and told him to go home and to take Pepcid AC which would help his face go back down. The swelling went down and was told to take it for a month. The next day the symptoms started going down and it took about a week for them to go away.